Literature DB >> 24345543

[Differentiation of species of Bupleurum and its changes].

Bao-Lin Zhao1.   

Abstract

Bupleurum is originated from the genus of Bupleurum chinensis DC of Umbelliferae. In China, the species of bupleurum for medicinal used are very complicate. During the Han-Tang Dynasties the bupleurum used covered a variety of its genera from Umbelliferae. "Yinzhou bupleurum" is the most famous in the Song Dynasty. Due to the continuous deterioration of its growing environment, the resources of the wild species of Yinzhou Bupleurum was declined, hence, those grown in other locations gradually attracted people's interests. Bupleutum was differentiated as Northern and Southern ones in the Ming Dynasty based on its different properties. Similar in its morphology and growing location to the Yinzhou Bupleurum, the Stellaria dichotoma lanceolata of the Caryophyllaceae was used as a substitute for the former. However, due to its prominent medicinal effects different from the Yinzhou one, the latter was continuously applied as a new herb. There are 2 great varieties of bupleurum used in modern times, the Bupleurum chinensis DC, and the Bupleurm scorzonerifolium Willd. Since the species of bupleurum in the current market are very complicate, and its clinical applications are quite confused, standardization and strengthening of its research are badly needed so as to promote its marketing.

Entities:  

Year:  2013        PMID: 24345543

Source DB:  PubMed          Journal:  Zhonghua Yi Shi Za Zhi        ISSN: 0255-7053


  2 in total

1.  Identification of Bupleurum (Apiaceae) seeds by allele-specific PCR based on ITS sequences.

Authors:  Wentao Qi; Julaiti Tuerxun; Jianchao Li; Chen Wang; Rong Luo; Changli Liu
Journal:  3 Biotech       Date:  2020-05-08       Impact factor: 2.406

2.  Protective effects of a traditional herbal extract from Stellaria dichotoma var. lanceolata against Mycobacterium abscessus infections.

Authors:  Su-Jin Bae; Jae-Won Choi; Byung-Joon Park; Jina Lee; Eun-Kyeong Jo; Young-Ha Lee; Sung-Bae Kim; Jae-Min Yuk
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.